BioWorld

Oct. 5, 2009

View Archived Issues

If This Is a 'V-Shaped'Recovery, Is That 'Victory' or 'Vanquished?'

Read More

New Studies Report Getting iPS Cells from Cord Blood

Read More

Pair Lighting 'Fuzeon' Merger; Trimeris, Korean Firm to Join From

Read More

Clinic Roundup

Read More

Stimulating Recovery Ahead? $5B in Fed Funds to Dole Out

Read More

Financings News

Read More

Other News to Note

Read More

Oncolytics' Phase III Borrows Adaptive Design in SPA Trial

Oncolytics Biotech Inc. reached agreement with the FDA on the design of a Phase III trial of Reolysin in head and neck cancer, marking the first such agreement for an intravenously administered oncolytic virus. (BioWorld Today) Read More

QLT Sheds Few Eligard Tears, Turns Eye to Punctal-Plug Bid

Read More